Fendrix

Fendrix is a vaccine designed to prevent hepatitis B infection. It contains aluminium phosphate and hepatitis B surface antigen, adjuvanted by AS04C and adsorbed on aluminium. This vaccine is administered intramuscularly and is manufactured by GlaxoSmithKline Biologicals S.A.

Fendrix is primarily used for the prevention of hepatitis B infection. It is suitable for individuals who are at risk of contracting the virus, including those with chronic liver disease or those who may be exposed to the virus through medical procedures. The vaccine works by stimulating the body's immune response to the hepatitis B surface antigen, helping to build immunity against the virus.

Common effects of Fendrix may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever, fatigue, or headache following vaccination. These effects are generally mild and short-lived, resolving within a few days.

Fendrix should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness. It is important to inform healthcare providers of any allergies or medical conditions before receiving the vaccine. Individuals who have had severe allergic reactions to previous doses of hepatitis B vaccines or any of its components should avoid Fendrix.

Fendrix may interact with other medications or vaccines. It is advisable to consult with a healthcare provider before receiving Fendrix if you are taking any other medications or have recently received other vaccines. Alcohol and certain immune-suppressing drugs may affect the vaccine's efficacy.